Blom B, Verschuren M C, Heemskerk M H, Bakker A Q, van Gastel-Mol E J, Wolvers-Tettero I L, van Dongen J J, Spits H
Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Blood. 1999 May 1;93(9):3033-43.
Recent studies have identified several populations of progenitor cells in the human thymus. The hematopoietic precursor activity of these populations has been determined. The most primitive human thymocytes express high levels of CD34 and lack CD1a. These cells acquire CD1a and differentiate into CD4(+)CD8(+) through CD3(-)CD4(+)CD8(-) and CD3(-)CD4(+) CD8alpha+beta- intermediate populations. The status of gene rearrangements in the various TCR loci, in particular of TCRdelta and TCRgamma, has not been analyzed in detail. In the present study we have determined the status of TCR gene rearrangements of early human postnatal thymocyte subpopulations by Southern blot analysis. Our results indicate that TCRdelta rearrangements initiate in CD34(+)CD1a- cells preceding those in the TCRgamma and TCRbeta loci that commence in CD34(+)CD1a+ cells. Furthermore, we have examined at which cellular stage TCRbeta selection occurs in humans. We analyzed expression of cytoplasmic TCRbeta and cell-surface CD3 on thymocytes that lack a mature TCRalphabeta. In addition, we overexpressed a constitutive-active mutant of p56(lckF505) by retrovirus-mediated gene transfer in sequential stages of T-cell development and analyzed the effect in a fetal thymic organ culture system. Evidence is presented that TCRbeta selection in humans is initiated at the transition of the CD3(-)CD4(+)CD8(-) into the CD4(+)CD8alpha+beta- stage.
最近的研究已经在人类胸腺中鉴定出了几种祖细胞群体。已经确定了这些群体的造血前体活性。最原始的人类胸腺细胞表达高水平的CD34且缺乏CD1a。这些细胞获得CD1a并通过CD3(-)CD4(+)CD8(-)和CD3(-)CD4(+)CD8α+β-中间群体分化为CD4(+)CD8(+)。尚未详细分析各种TCR基因座,特别是TCRδ和TCRγ中的基因重排状态。在本研究中,我们通过Southern印迹分析确定了人类出生后早期胸腺细胞亚群的TCR基因重排状态。我们的结果表明,TCRδ重排在CD34(+)CD1a-细胞中开始,早于在CD34(+)CD1a+细胞中开始的TCRγ和TCRβ基因座中的重排。此外,我们研究了人类TCRβ选择发生在哪个细胞阶段。我们分析了缺乏成熟TCRαβ的胸腺细胞上细胞质TCRβ和细胞表面CD3的表达。此外,我们通过逆转录病毒介导基因转移在T细胞发育的连续阶段过表达p56(lckF505)的组成型活性突变体,并在胎儿胸腺器官培养系统中分析其作用。有证据表明,人类TCRβ选择在CD3(-)CD4(+)CD8(-)向CD4(+)CD8α+β-阶段转变时开始。